[go: up one dir, main page]

DK196189D0 - Oralt osmotisk dispenseringssystem indeholdende et farmakologisk aktivt stof - Google Patents

Oralt osmotisk dispenseringssystem indeholdende et farmakologisk aktivt stof

Info

Publication number
DK196189D0
DK196189D0 DK196189A DK196189A DK196189D0 DK 196189 D0 DK196189 D0 DK 196189D0 DK 196189 A DK196189 A DK 196189A DK 196189 A DK196189 A DK 196189A DK 196189 D0 DK196189 D0 DK 196189D0
Authority
DK
Denmark
Prior art keywords
active substance
dispensing system
system containing
oral osmotic
pharmacological active
Prior art date
Application number
DK196189A
Other languages
English (en)
Other versions
DK196189A (da
DK175232B1 (da
Inventor
Shailesh B Shah
Arun Dattatreya Koparkar
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK196189D0 publication Critical patent/DK196189D0/da
Publication of DK196189A publication Critical patent/DK196189A/da
Application granted granted Critical
Publication of DK175232B1 publication Critical patent/DK175232B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Confectionery (AREA)
DK198901961A 1988-04-25 1989-04-24 Oralt osmotisk dispenseringssystem indeholdende et farmakologisk aktivt stof DK175232B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/185,564 US4892739A (en) 1988-04-25 1988-04-25 Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
US18556488 1988-04-25

Publications (3)

Publication Number Publication Date
DK196189D0 true DK196189D0 (da) 1989-04-24
DK196189A DK196189A (da) 1989-10-26
DK175232B1 DK175232B1 (da) 2004-07-19

Family

ID=22681522

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198901961A DK175232B1 (da) 1988-04-25 1989-04-24 Oralt osmotisk dispenseringssystem indeholdende et farmakologisk aktivt stof

Country Status (22)

Country Link
US (1) US4892739A (da)
EP (1) EP0339506B1 (da)
JP (1) JP2750150B2 (da)
KR (1) KR0125935B1 (da)
AT (1) ATE75939T1 (da)
AU (1) AU618083B2 (da)
CA (1) CA1334382C (da)
DD (1) DD288093A5 (da)
DE (1) DE58901373D1 (da)
DK (1) DK175232B1 (da)
ES (1) ES2031302T3 (da)
FI (1) FI90203C (da)
GR (1) GR3005399T3 (da)
HU (1) HU201469B (da)
IE (1) IE61223B1 (da)
IL (1) IL90019A (da)
MX (1) MX15754A (da)
NO (1) NO175186C (da)
NZ (1) NZ228845A (da)
PH (1) PH27150A (da)
PT (1) PT90341B (da)
ZA (1) ZA892998B (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023076A (en) * 1987-02-27 1991-06-11 Alza Corporation Lamina comprising carboxyvinyl polymer
US5156850A (en) * 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
US5232705A (en) * 1990-08-31 1993-08-03 Alza Corporation Dosage form for time-varying patterns of drug delivery
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
US8524277B2 (en) * 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6099862A (en) 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
SE0003125D0 (sv) * 2000-09-05 2000-09-05 Astrazeneca Ab Modified polymers
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
KR20030061392A (ko) 2000-11-03 2003-07-18 안드렉스 코포레이션 방출 조절성 메트포민 조성물
US6790459B1 (en) 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin
US6610326B2 (en) 2001-02-16 2003-08-26 Andrx Corporation Divalproex sodium tablets
US7776345B2 (en) * 2001-07-04 2010-08-17 Sun Pharma Advanced Research Company Ltd Gastric retention controlled drug delivery system
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
AU2003241537A1 (en) * 2002-05-23 2003-12-12 Andrx Corporation Biguanide formulations
US20050051922A1 (en) * 2002-09-20 2005-03-10 Avinash Nangia Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
US20050048119A1 (en) * 2002-09-20 2005-03-03 Avinash Nangia Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
WO2004026241A2 (en) 2002-09-20 2004-04-01 Andrx Labs Llc Multistage formulation containing a biguanide and thiazolidindione derivatives
AU2003903507A0 (en) 2003-07-08 2003-07-24 U. S. Filter Wastewater Group, Inc. Membrane post-treatment
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US20050196447A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196446A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196442A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196448A1 (en) * 2004-03-05 2005-09-08 Hai Yong Huang Polymeric compositions and dosage forms comprising the same
BRPI0507439A (pt) * 2004-03-05 2007-07-03 Mcneil Ppc Inc composições poliméricas e formas de dosagem compreendendo as mesmas
US20050287185A1 (en) * 2004-06-23 2005-12-29 David Wong Extended release oxybutynin formulation
JP2008505197A (ja) * 2004-07-05 2008-02-21 シーメンス・ウォーター・テクノロジーズ・コーポレーション 親水性膜
IL166114A0 (en) * 2005-01-03 2006-01-15 Calcident Active Ltd Long-acting controlled-release pharmaceutical preparation for use in the oral cavity
CN102670539A (zh) * 2011-03-14 2012-09-19 北京天衡药物研究院 琥珀酸美托洛尔渗透泵控释片
CN102670555A (zh) * 2011-03-14 2012-09-19 北京天衡药物研究院 富马酸美托洛尔渗透泵控释片
WO2014043315A1 (en) 2012-09-14 2014-03-20 Evoqua Water Technologies Llc A polymer blend for membranes
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
CN107847869B (zh) 2015-07-14 2021-09-10 罗门哈斯电子材料新加坡私人有限公司 用于过滤系统的通气装置
US20210283046A1 (en) * 2018-07-24 2021-09-16 Bayer Aktiengesellschaft Pharmaceutical dosage form which can be administered orally and has modified release
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
JP2023541448A (ja) * 2020-09-15 2023-10-02 シンアジャル コーポレイション 薬物を口の中へ連続的に押し出すためのデバイス及び方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4326525A (en) * 1980-10-14 1982-04-27 Alza Corporation Osmotic device that improves delivery properties of agent in situ
US4439195A (en) * 1980-10-14 1984-03-27 Alza Corporation Theophylline therapy
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4455143A (en) * 1982-03-22 1984-06-19 Alza Corporation Osmotic device for dispensing two different medications
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
JPH0759499B2 (ja) * 1984-02-10 1995-06-28 ベンツォン ファーマ エイ/エス 拡散被覆された複合単位服用剤
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom
US4693886A (en) * 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
DE3778662D1 (de) * 1986-11-14 1992-06-04 Ciba Geigy Ag Orales osmotisches system fuer metoprolol mit verbesserten formulierungseigenschaften.

Also Published As

Publication number Publication date
DK196189A (da) 1989-10-26
FI891921A0 (fi) 1989-04-21
NO891680L (no) 1989-10-26
AU618083B2 (en) 1991-12-12
FI891921A7 (fi) 1989-10-26
EP0339506B1 (de) 1992-05-13
PT90341A (pt) 1989-11-10
CA1334382C (en) 1995-02-14
HUT50625A (en) 1990-03-28
IL90019A0 (en) 1989-12-15
US4892739A (en) 1990-01-09
FI90203B (fi) 1993-09-30
IE891316L (en) 1989-10-25
NO175186B (da) 1994-06-06
EP0339506A1 (de) 1989-11-02
ZA892998B (en) 1989-12-27
DE58901373D1 (de) 1992-06-17
NO175186C (no) 1994-09-14
KR0125935B1 (ko) 1997-12-26
MX15754A (es) 1994-01-31
HU201469B (en) 1990-11-28
ATE75939T1 (de) 1992-05-15
AU3268789A (en) 1989-10-26
DK175232B1 (da) 2004-07-19
KR900015734A (ko) 1990-11-10
GR3005399T3 (da) 1993-05-24
ES2031302T3 (es) 1992-12-01
IL90019A (en) 1994-04-12
FI90203C (fi) 1994-01-10
JPH029815A (ja) 1990-01-12
PH27150A (en) 1993-04-02
JP2750150B2 (ja) 1998-05-13
PT90341B (pt) 1994-08-31
NZ228845A (en) 1990-10-26
DD288093A5 (de) 1991-03-21
IE61223B1 (en) 1994-10-19
NO891680D0 (no) 1989-04-24

Similar Documents

Publication Publication Date Title
DK196189D0 (da) Oralt osmotisk dispenseringssystem indeholdende et farmakologisk aktivt stof
ATE151285T1 (de) Orale arzneimittel mit kolonspezifischer freisetzung
DK1035834T3 (da) Osmotisk doseringsform omfattende en første og anden coating
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
DE69923200D1 (de) Neue oral anzuwendende arzneizubereitungen für rivastigmine mit kontrollierter wirkstoffabgabe
DE69106501D1 (de) Osmotisches dosiersystem zur verabreichung von flüssigen arzneimitteln.
ES2023649B3 (es) Formas de dosificacion y administracion para medicamentos, reactivos o similares asi como procedimiento para su obtencion.
DK618088A (da) Farmaceutisk doseringsform til kontrolleret afgivelse af aktivt stof
GR1002564B (el) Στερεα απο του στοματος χορηγουμενη φαρμακευτικη μορφη δοσιμετρησεως προγραμματισμενου ρυθμου απελευθερωσεως.
SE8601791D0 (sv) Osmotisk anordning med sjelvforseglande passage
FI853934L (fi) Doseringssystem som bestaor av flera enheter och har en belaeggning som tillaoter diffusion.
DE3863366D1 (de) Antibiotikum vermisporin, verfahren zu dessen herstellung und dasselbe als aktiver antibakterieller wirkstoff enthaltende pharmazeutische zusammensetzung.
FI932553A7 (fi) Uusia farmaseuttisia formulaatioita, jotka sisältävät farmakologisesti aktiivista ionisoitavaa ainetta, sekä menetelmä niiden valmistamiseksi
ES2021028B3 (es) Dispositivo para liberacion de farmacos en 2 etapas.
SE8701479D0 (sv) Metod for inneslutning av biologiskt verksamma preparat samt anvendning derav
ES2007040A6 (es) Un forma de dosificacion para descargar un agente benificioso a un entorno fluido de uso
NZ238867A (en) Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
MY103627A (en) A controlled release pharmaceutical dosage form and a process for preparing same.
IT1244037B (it) Forma farmaceutica a rilascio selettivo nel colon

Legal Events

Date Code Title Description
PUP Patent expired